Who owns AtriCure, Inc. (ATRC)? Elite investor 13F holders

4 tracked elite investors reported holding AtriCure, Inc as of 2026-06-30, including Renaissance Technologies LLC, First Eagle Investment Management, D.E. Shaw, Bridgewater Associates. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

4 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Health Care Equipment & Services

AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products;…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Renaissance Technologies LLCATRICURE INCSHARE2026-06-302026-08-13 00:00:006550118.00 USD234100.000000SharesreduceOriginal filing
First Eagle Investment ManagementATRICURE INCSHARE2026-06-302026-08-05 00:00:008328051.00 USD297643.000000SharesaddOriginal filing
D.E. ShawATRICURE INCSHARE2026-06-302026-08-14 00:00:005395216.00 USD192824.000000SharesaddOriginal filing
Bridgewater AssociatesATRICURE INCSHARE2026-06-302026-08-14 00:00:002135070.00 USD76307.000000SharesaddOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown